Key result
The CyberCardia project surveys recent progress in developing an in silico design methodology for implantable cardiac devices to accelerate medical-device innovation and improve system verification.
The CyberCardia project aims to develop an in silico design methodology for implantable cardiac devices to accelerate innovation and ensure device safety.
Answers are grounded in this paper and cite their sources.
May accelerate cardiac device innovation via in silico methods; leaves open prospective clinical and regulatory validation.
In this paper, we survey recent progress in CyberCardia project, a CPS Frontier project funded by the National Science Foundation. The CyberCardia project will lead to significant advances in the state of the art for system verification and cardiac therapies based on the use of formal methods and closed-loop control and verification. The animating vision for the work is to enable the development of a true in silico design methodology for medical devices that can be used to speed the development of new devices and to provide greater assurance that their behavior matches designer intentions, and to pass regulatory muster more quickly so that they can be used on patients needing their care. The acceleration in medical-device innovation achievable as a result of the CyberCardia research will also have long-term and sustained societal benefits, as better diagnostic and therapeutic technologies enter into the practice of medicine more quickly.
No takes yet. Share an insight, caveat, or question.
Islam et al. (2016) conducted a review in Implantable cardiac devices. In silico design methodology was evaluated. The CyberCardia project surveys recent progress in developing an in silico design methodology for implantable cardiac devices to accelerate medical-device innovation and improve system verification.
Synapse has enriched 10 related papers. Consider them for comparative context: